Northern Trust Corp Nuvation Bio Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,523,124 shares of NUVB stock, worth $4.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,523,124

Previous 1,267,315 20.19%

Holding current value

$4.3 Million

Previous $3.7 Million 5.32%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.3 - $3.83 $588,360 - $979,748	255,809 Added 20.19%	1,523,124 $3.5 Million
Q2 2024 Aug 14, 2024	BUY	$2.58 - $3.69 $92,823 - $132,758	35,978 Added 2.92%	1,267,315 $3.7 Million
Q1 2024 May 14, 2024	BUY	$1.46 - $3.97 $16,206 - $44,067	11,100 Added 0.91%	1,231,337 $4.48 Million
Q4 2023 Feb 13, 2024	SELL	$0.96 - $1.53 $77,374 - $123,314	-80,598 Reduced 6.2%	1,220,237 $1.84 Million
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.1 $62,119 - $103,532	49,301 Added 3.94%	1,300,835 $1.74 Million
Q2 2023 Aug 11, 2023	BUY	$1.56 - $1.84 $279,219 - $329,336	178,987 Added 16.69%	1,251,534 $2.25 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $8,038 - $12,459	5,024 Added 0.47%	1,072,547 $1.78 Million
Q4 2022 Feb 13, 2023	BUY	$1.68 - $2.5 $66,351 - $98,737	39,495 Added 3.84%	1,067,523 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$0.29 - $4.04 $2,397 - $33,394	-8,266 Reduced 0.8%	1,028,028 $2.3 Million
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $1.06 Million - $1.92 Million	-327,805 Reduced 24.03%	1,036,294 $3.36 Million
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $236,196 - $453,394	-51,347 Reduced 3.63%	1,364,099 $7.18 Million
Q4 2021 Feb 08, 2022	BUY	$7.75 - $10.05 $5.19 Million - $6.73 Million	669,667 Added 89.79%	1,415,446 $12 Million
Q3 2021 Nov 15, 2021	BUY	$7.78 - $10.0 $2.07 Million - $2.66 Million	265,917 Added 55.42%	745,779 $7.41 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $3.33 Million - $5.23 Million	361,300 Added 304.74%	479,862 $4.47 Million
Q1 2021 May 12, 2021	BUY	$9.0 - $14.57 $1.07 Million - $1.73 Million	118,562 New	118,562 $1.24 Million

Others Institutions Holding NUVB

# of Institutions

158

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $613M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Nuvation Bio Inc. Transaction History